Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Jaipur
Clinical trial register · India

Clinical Trials in Jaipur, 2026

Every study on the ClinicalTrials.gov registry that lists a site in India and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 1120 matching records held by the registry are in this view. Synced 08 Nov 2026, 03:16 UTC
1120
Studies in scope
all four open statuses
608
Recruiting now
open to new participants
218
Lead sponsors
across recruiting studies
Top sites
New Delhi 339 Mumbai 260 Hyderabad 233 Bangalore 199 Pune 186
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca18 Janssen Research & Development, LLC9 Eli Lilly and Company8 Novo Nordisk A/S5 Pfizer5
Site location
New Delhi339 Mumbai260 Hyderabad233 Bangalore199 Pune186
All 274 locations
Target enrolment
to

Trials with a site in Jaipur

100 of 1120 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Indian sites
Start
Not yet open
Wockhardt
Phase 3
324
Gurgaon, Mumbai, Pune, New Delhi, Pimpri-Chinchwad, Jaipur, Chengalpattu, Secunderabad
2026-10-28
Not yet open
Indira IVF Hospital Pvt Ltd
Not applicable
830
Patna, Bangalore, Bhāndup, Pune, Delhi, Jaipur, Udaipur, Allahābād
2026-10-05
Not yet open
Azafaros B.V.
Phase 2
20
Jaipur, New Delhi
2026-09-28
Recruiting
Eli Lilly and Company
Phase 3
2,001
Aligarh, Baroda, Guntur, Hubli, Jaipur, Mysore, Nagpur, Trivandrum
2026-08-26
Recruiting
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
NCT07761117Heart Failure With Preserved Ejection Fraction (HFpEF), Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF)
DrugElecoglipron
AstraZeneca
Phase 3
6,950
Belagavi, Calicut, Coimbatore, Dehradun, Delhi, Hyderabad, Jaipur, Kanpur
2026-08-24
Recruiting
AstraZeneca
Phase 3
2,500
Bhubaneswar, Coimbatore, Hyderabad, Indore, Jaipur, Jodhpur, Kochi, Kolkata
2026-08-19
Not yet open
Indira IVF Hospital Pvt Ltd
Not applicable
860
Patna, Bangalore, Bhāndup, Pune, Delhi, Jaipur, Allahābād, Lucknow
2026-07-17
Recruiting
Novartis Pharmaceuticals
Phase 3
570
Nashik, Jaipur, Belagavi
2026-07-16
Recruiting
AstraZeneca
Phase 3
2,000
Bangalore, Belagavi, Calicut, Chennai, Coimbatore, Guwahati, Indore, Jaipur
2026-07-06
Recruiting
AstraZeneca
Phase 3
4,500
Bangalore, Belagavi, Bikaner, Delhi, Guntur, Hyderabad, Jaipur, Jodhpur
2026-06-29
Recruiting
Pfizer
Phase 3
540
Visakhapatnam, Bangalore, Belagavi, Nashik, Pune, Dwarka, New Delhi, Jaipur
2026-06-22
Recruiting
Janssen Research & Development, LLC
Phase 3
700
Bengaluru, Gūrgaon, Jaipur, Kolkata, New Delhi, Pune
2026-05-31
Recruiting
Janssen Research & Development, LLC
Phase 3
644
Hubli, Hyderabad, Jaipur, Kochi, Mumbai (ex Bombay), Secunderabad, Surat
2026-05-23
Recruiting
Janssen Research & Development, LLC
Phase 3
460
Hubli, Hyderabad, Jaipur, Kochi, Mumbai (ex Bombay), Secunderabad, Surat
2026-05-22
Recruiting
Lumos Pharma
Phase 3
150
Mumbai, Nashik, Jaipur, Madurai, Chandigarh
2026-05-20
Recruiting
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
NCT07415044Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate, Ulcerative Colitis, Active Severe
DrugZotemtegrast
Eli Lilly and Company
Phase 2
1,431
Allahabād, Belagavi, Belgavi, Hyderabad, Jaipur, Kochi, Lucknow, Mumbai
2026-03-26
Recruiting
Laboratoires Thea
Phase 2
120
Kolkata, Ahmedabad, Bangalore, Hyderabad, Jaipur, Patna, Pune, Surat
2026-03-24
Recruiting
Pfizer
Phase 2/3
1,156
Belagavi, Thane, New Delhi, Jaipur, Coimbatore, Hyderabad, Dehradun, Kolkata
2026-02-11
Recruiting
Eli Lilly and Company
Phase 3
900
Allahabād, Bangalore, Chennai, Hyderabad, Jaipur, Kanpur, Kolhāpur, Mysore
2026-02-10
Recruiting
Janssen Research & Development, LLC
Phase 3
600
Chennai, Jaipur, Kolkata, Nashik, New Delhi, Vadodara
2025-12-03
Recruiting
Eli Lilly and Company
Phase 3
1,205
Aligarh, Jaipur, Kolkata, Kozhikode, Nagpur, Nashik, New Delhi, Rishikesh
2025-10-31
Recruiting
Eli Lilly and Company
Phase 3
4,500
Ahmedabad, Bhubaneswar, Chandigarh, Ernākulam, Guntur, Hyderabad, Jaipur, Kochi
2025-10-15
Recruiting
Janssen Research & Development, LLC
Phase 2/3
1,092
Bangalore, Bengaluru, Bhubaneswar, Gurugram, Hyderabad, Jaipur, Kochi, Ludhiana
2025-10-03
Recruiting
Pfizer
Phase 2/3
982
Mumbai, New Delhi, Jaipur, Kolkata
2025-10-03
Active, closed
Janssen Research & Development, LLC
Phase 3
896
Bangalore, Bengaluru, Bhubaneswar, Ernākulam, Gurugram, Hyderabad, Jaipur, Ludhiana
2025-10-01
Recruiting
Genentech, Inc.
Phase 2
224
Hyderabad, Rajkot, Nagpur, Jaipur, Kolkata
2025-09-29
Recruiting
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
NCT07157774Elevated Lp(a), Atherosclerotic Cardiovascular Disease (ASCVD)
Eli Lilly and Company
Phase 3
10,450
Belagavi, Belgavi, Jaipur, Kanpur, Kozhikode, Lucknow, Nagpur, Nashik
2025-09-02
Recruiting
Novo Nordisk A/S
Phase 4
64
Belagavi, Mysore, Kozhikode, Mumbai, New Delhi, Jaipur, Udaipur, Hyderabad
2025-08-26
Active, closed
Sanofi
Phase 4
110
Bengaluru, Jaipur, Kolkata, Nagpur, New Delhi, Pune, Vizianagaram
2025-07-31
Active, closed
Effects of a Financial Literacy and Gender-Transformative Couples Intervention on Parenting Practices in India
NCT07651670Parenting Practices, Intimate Partner Violence (IPV), Mental Health, Empowerment
Shruti Shukla
Not applicable
4,552
Visakhapatnam, Mumbai, Jaipur, Noida
2025-07-29
Not yet open
Efficacy, Safety and Pharmacokinetic of Virchow IVIG in PID Patients
NCT07017036Primary Immunodeficiency Diseases (PID)
Virchow Group
Phase 3
44
Nagpur, Jaipur
2025-07-01
Recruiting
Azafaros B.V.
Phase 3
147
Ernākulam, New Delhi, Jaipur, Vellore
2025-06-30
Active, closed
Azafaros B.V.
Phase 3
75
Ernākulam, New Delhi, Jaipur
2025-06-30
Recruiting
Azafaros B.V.
Phase 3
72
Ernākulam, New Delhi, Jaipur, Vellore
2025-06-30
Recruiting
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
NCT07012395Ulcerative Colitis, Inflammatory Bowel Diseases, Colitis, Colitis, Ulcerative
DrugsSPY001·SPY002·SPY003
Spyre Therapeutics, Inc.
Phase 2
645
New Delhi, Hyderabad, Jaipur, Kochi, Sūrat
2025-05-27
Active, closed
Johnson & Johnson Private Limited
Phase 4
75
Bangalore, Bengaluru, Chandigarh, Jaipur, Kolkata, Mumbai, Nagpur, New Delhi
2025-05-22
Recruiting
Hoffmann-La Roche
Phase 3
425
Kurnool, Rajkot, Surat, Kochi, Nagpur (urban), New Delhi, Jaipur, Gachibowli
2025-05-12
Recruiting
Hoffmann-La Roche
Phase 3
600
Kurnool, Rajkot, Surat, Kochi, Nagpur (urban), New Delhi, Jaipur, Gachibowli
2025-03-17
Not yet open
Vedic Lifesciences Pvt. Ltd.
Not applicable
150
Ahmedabad, Pune, Jaipur, Varanasi, Delhi
2025-02-10
Active, closed
Hoffmann-La Roche
Phase 3
350
Surat, Nagpur (urban), Jaipur, Secunderabad
2024-12-11
Recruiting
Novo Nordisk A/S
Phase 2
465
Guntur, Bengaluru, Kozhikode, Jaipur, Hyderabad
2024-12-02
Recruiting
Boehringer Ingelheim
Phase 3
1,590
Ahemdabad, Chandigarh, Hyderabad, Afzalgunj, Jaipur, Lucknow, Nagpur, New Delhi, Rohtak
2024-11-12
Recruiting
Boehringer Ingelheim
Phase 3
1,800
Ahemdabad, Chandigarh, Hyderabad, Afzalgunj, Jaipur, Lucknow, Mohali, Nagpur, New Delhi
2024-10-14
Active, closed
Novartis Pharmaceuticals
Phase 2
201
Kochi, Mumbai, New Delhi, Jaipur
2024-10-09
Active, closed
Regeneron Pharmaceuticals
Phase 2
19
Ahmedabad, Surat, Kochi, Mumbai, New Delhi, Jaipur
2024-09-30
Active, closed
Hoffmann-La Roche
Phase 3
400
Surat, Jaipur
2024-09-17
Active, closed
Celldex Therapeutics
Phase 3
976
Surat, Vadodara, Nagpur, Nashik, Pune, Jaipur, Kanpur, Ahmedabad
2024-07-19
Recruiting
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)
Phase 2
385
Ahmedabad, Bhubaneswar, Coimbatore, Jaipur, Kochi, Ludhiana, New Delhi, Pune
2024-07-18
Recruiting
Nemours Children's Clinic
Not applicable
800
Belagavi, Chandrapur, Nagpur, Pune, Wardha, Jaipur, Hyderabad
2024-07-01
Recruiting
AstraZeneca
Phase 3
675
Chennai, Dwārka, Jaipur, Kolkata, Marg Jaipur, Nagpur, Nashik, New Delhi
2024-04-11
Active, closed
Samsung Bioepis Co., Ltd.
Phase 3
555
Bangalore, Bhubaneswar, Erandwane, Hyderabad, Jaipur, Mumbai, Sūrat, Udaipur
2024-03-12
Recruiting
Novartis Pharmaceuticals
Phase 2
108
Belagavi, Mumbai, Pune, Jaipur, Chennai
2024-02-20
Recruiting
AstraZeneca
Phase 3
1,145
Bengaluru, Hyderabad, Jaipur, Kanpur, Kochi, Kolkata, Lucknow, Madurai
2023-12-14
Recruiting
AstraZeneca
Phase 3
625
Calicut, Chennai, Jaipur, Kochi, Kolkata, Kottayam, Marg Jaipur, Mohali
2023-11-23
Recruiting
AstraZeneca
Phase 3
800
Calicut, Jaipur, Lucknow, Madurai, Mohali, Nagpur, Nashik, New Delhi
2023-09-22
Active, closed
A Study of Zigakibart in Adults With IgA Nephropathy
NCT05852938IgA Nephropathy, Immunoglobulin A Nephropathy
DrugZigakibart
Novartis Pharmaceuticals
Phase 3
383
Hyderabad, Chandigarh, Faridabad, Bengaluru, Trivandrum, Jaipur, Vellore, Lucknow
2023-07-06
Recruiting
P+F Products + Features GmbH
Not applicable
267
Bangalore, Gūrgaon, Jaipur, Kochi, Vellore
2023-07-03
Active, closed
Hoffmann-La Roche
Phase 3
2,000
Hyderabad, Ahmedabad, Faridabad, Hubli, Nagpur, Pune, Ajmer, Jaipur
2023-06-28
Active, closed
Alumis Inc
Phase 2
408
New Delhi, Ahmedabad, Bangalore, Bengaluru, Chandigarh, Haryāna, Jaipur, Lucknow
2023-06-26
Active, closed
Population Health Research Institute
Not applicable
5,100
Ernākulam, Kollam, Kottayam, Indore, Jaipur, Chennai, Madurai, Gurugramam
2023-06-22
Recruiting
AstraZeneca
Phase 3
4,300
Bangalore, Belagavi, Bhubaneswar, Hubli, Hyderabad, Jaipur, Kolkata, Mumbai
2023-03-31
Active, closed
Janssen Research & Development, LLC
Phase 3
614
Gūrgaon, Jaipur, Pune
2023-03-29
Recruiting
Regeneron Pharmaceuticals
Phase 3
202
Kochi, Mumbai, New Delhi, Chandigarh, Jaipur
2023-03-07
Active, closed
A Research Study Looking at Long-term Treatment With Mim8 in People With Haemophilia A
NCT05685238Haemophilia A, Haemophilia A With Inhibitors
Novo Nordisk A/S
Phase 3
451
Surat, Mumbai, Pune, Ludhiana, Jaipur, Ranipet, Noida
2023-02-13
Active, closed
Oregovomab Plus Chemotherapy in Neo-adjuvant Setting in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer
NCT05605535Ovarian Neoplasm Epithelial, Ovarian Cancer, Fallopian Tube Neoplasms, Peritoneal Carcinoma
DrugsOregovomab·Paraplatin·Taxol·Paclitaxel
CanariaBio Inc.
Phase 2
88
Visakhapatnam, Vadodara, Belagavi, Kochi, Trivandrum, Puducherry, Jaipur, Chennai
2023-02-07
Active, closed
AstraZeneca
Phase 3
1,350
Calicut, Delhi, Jaipur, Kolkata, Madurai, Puducherry
2022-12-29
Active, closed
Viatris Innovation GmbH
Phase 3
470
Ahmedabad, Bangalore, Chennai, Hyderabad, Jaipur, Nagpur, Nashik, Pune
2022-12-13
Active, closed
Celcuity Inc
Phase 3
701
Jaipur, Bangalore, Chandigarh, Kolkata, Navi Mumbai, Vellore
2022-12-08
Active, closed
Sanofi
Phase 2
187
Gūrgaon, Jaipur, Kochi, Ludhiana, New Delhi, Pune, Rajkot, Secunderabad
2022-11-25
Active, closed
Post Graduate Institute of Medical Education and Research, Chandigarh
Phase 4
144
Chandigarh, Hyderabad, Jaipur, Jodhpur, Lucknow, New Delhi, Rishikesh, Vellore
2022-11-23
Active, closed
Comparative Outcomes Related to Delivery-room Cord Milking In Low-resourced Kountries
NCT03657394Hypoxic-Ischemic Encephalopathy, Birth Asphyxia
Nemours Children's Clinic
Not applicable
3,442
Belagavi, Nagpur, Pune, Chandrapur, Wardha, Jaipur
2022-10-17
Active, closed
Nemours Children's Clinic
Not applicable
3,442
Belagavi, Nagpur, Pune, Chandrapur, Wardha, Jaipur
2022-10-17
Active, closed
Janssen Research & Development, LLC
Phase 2
577
Bangalore, Bhubaneswar, Jaipur, New Delhi, Secunderabad, Surat
2022-09-19
Active, closed
AstraZeneca
Phase 3
594
Jaipur, Pune, Surat
2022-09-15
Active, closed
AstraZeneca
Phase 3
644
Bangalore, Jaipur, Kolkata, Nagpur, Nashik, New Delhi, Puducherry, Vadodara
2022-05-16
Active, closed
AstraZeneca
Phase 3
760
Ahmedabad, Bangalore, Delhi, Hyderabad, Jaipur, Kolkata, Mumbai, New Delhi
2022-03-28
Active, closed
Novo Nordisk A/S
Phase 3
153
Guwahati, Surat, Kolhāpur, Mumbai, Pune, Cuttack, Jaipur, Noida
2022-03-24
Active, closed
AstraZeneca
Phase 3
791
Ahmedabad, Bangalore, Delhi, Howrah, Hyderabad, Jaipur, Kolkata, Marg Jaipur
2022-02-18
Recruiting
World Health Organization
Not applicable
12,612
Jaipur
2022-01-01
Active, closed
Sanofi
Phase 4
1,339
Ahmedabad, Chandigarh, Coimbatore, Jaipur, Jodhpur, Kozhikode, Lucknow, Mangaluru
2021-12-16
Active, closed
AstraZeneca
Phase 3
148
Bangalore, Belagavi, Jaipur, Mysore, Nashik
2021-10-28
Active, closed
AstraZeneca
Phase 3
732
Gūrgaon, Howrah, Hyderabad, Jaipur, Kolkata, Nashik, Surat, Visakhapatnam
2021-10-18
Recruiting
Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs
NCT04613921Liver Diseases, Liver Cirrhosis, Acute-On-Chronic Liver Failure, Liver Transplant; Complications
European Foundation for Study of Chronic Liver Failure
Observational
3,000
Bengaluru, Mumbai, New Delhi, Jaipur, Chennai, Gurugramam, Kochi, Secunderabad
2021-07-08
Active, closed
D9319C00001- 1L OC Mono Global RCT
NCT04884360Ovarian Cancer
DrugOlaparib
AstraZeneca
Phase 3
366
Gūrgaon, Jaipur, Kolkata, Madurai, Namakkal, Nashik, New Delhi
2021-05-31
Active, closed
Pfizer
Phase 3
841
Mumbai, Pune, Thane, New Delhi, Jaipur
2020-12-21
Recruiting
Mirati Therapeutics Inc.
Phase 2/3
626
Ahemdabad, Ahmedabad, Bangalore, Belagavi, Chhatrapati Sambhajinagar, Howrah, Hyderabad, Jaipur
2020-12-02
Active, closed
Eli Lilly and Company
Phase 3
996
Chandigarh, Surat, Pune, New Delhi, Ludhiana, Jaipur, Chennai
2020-06-22
Active, closed
Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia Without Inhibitors
NCT04082429Haemophilia A Without Inhibitors, Haemophilia B Without Inhibitors
DrugConcizumab
Novo Nordisk A/S
Phase 3
156
Bangalore, Pune, Jaipur, Ranipet
2019-11-13
Active, closed
Pfizer
Phase 3
896
Surat, Gurgaon, Nagpur, Pune, Jaipur, Kanpur
2019-09-05
Active, closed
Eli Lilly and Company
Phase 3
1,058
Ahmedabad, Bangalore, Hyderabad, Jaipur, Ludhiana, Nagpur, Noida, Pune
2018-07-18
Active, closed
Janssen Research & Development, LLC
Phase 2/3
1,409
Jaipur, New Delhi, Noida, Rajkot, Surat
2018-04-13
Active, closed
Dayanand Medical College and Hospital
Phase 3
174
Ludhiana, Chandigarh, Hyderabad, Jaipur, New Delhi
2017-11-14
Active, closed
A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis
NCT03165734Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis
DrugPacritinib
Swedish Orphan Biovitrum
Phase 3
407
Guwahati, Chandigarh, Surat, Gurgaon, Pune, Jaipur, Madurai, Hyderabad
2017-06-26
Recruiting
Tata Memorial Centre
Not applicable
1,022
Chandigarh, Kolhāpur, Mumbai, Delhi, New Delhi, Jaipur
2016-05-27
Active, closed
Gilead Sciences
Phase 3
90
Surat, Gurgaon, Nagpur, Jaipur, Lucknow, Bangalore
2012-12-06
Recruiting
Product Surveillance Registry
NCT01524276Cardiac Rhythm Disorders, Urological Disorders, Neurological Disorders, Cardiovascular Disorders
Medtronic
Observational
100,000
Jaipur, Hyderabad, Bangalore, Bengaluru, Chennai, Gūrgaon, Kochi, New Delhi
2012-01
Active, closed
AstraZeneca
Phase 3
736
Ansārinagar, Bhopal, Hyderabad, Jaipur, Kolkata, Manipal, Marg Jaipur, Mumbai
2005-02-13
Recruiting
Prospective Urban Rural Epidemiology Study
NCT03225586Cardiovascular Diseases, Risk Factor, Cardiovascular, Health Behavior, Environmental Exposure
Population Health Research Institute
Observational
200,000
Bangalore, Thiruvananthapuram, Jaipur, Chennai, Chandigarh
2002-01-01
Recruiting
International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry
NCT00358943Gaucher Disease, Cerebroside Lipidosis Syndrome, Glucocerebrosidase Deficiency Disease, Glucosylceramide Beta-Glucosidase Deficiency Disease
Genzyme, a Sanofi Company
Observational
12,000
Ahmedabad, Jaipur, Kolkata, Mumbai, Secunderabad, Vellore
1991-04-01
Recruiting
Medtronic
Observational
20,000
Bangalore, Chennai, Gūrgaon, Hyderabad, Jaipur, Kochi, New Delhi, Vadapalani
1983-01
Rows per page Showing 1–100 of 100
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Indian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 8 November 2026. https://priyalifescience.com/clinical-trials-india/city/jaipur

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in India and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 1,120 studies in total at the last sync on 08 Nov 2026, 03:16 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 100 of those studies with a site in Jaipur.

How many clinical trials are recruiting in Jaipur?

49 of the 100 studies on this page are recruiting new participants as of the 08 Nov 2026, 03:16 UTC sync. A further 6 have not yet opened recruitment, 45 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Jaipur), 100 studies
PhaseStudiesRecruitingShare
Phase 3602860%
Phase 214714%
Not applicable11411%
Observational555%
Phase 2/3545%
Phase 4515%

Most active sponsors

Lead sponsors with the most studies (Jaipur)
Lead sponsorStudiesRecruiting
AstraZeneca189
Janssen Research & Development, LLC95
Eli Lilly and Company86
Hoffmann-La Roche52
Novo Nordisk A/S52
Pfizer53
Azafaros B.V.42
Novartis Pharmaceuticals42
Nemours Children's Clinic31
Sanofi30
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.